Associated Papers
Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer.
Li X et al.
Cancer Cell, 2023
37478850 (PubMed )
Supplement: NIHMS1916204-supplement-MMC4.xlsx › Cosmic_gene_mutations
Epigenetic modifiers DNMT3A and BCOR are recurrently mutated in CYLD cutaneous syndrome.
Davies HR et al.
Nature Communications, 2019
31624251 (PubMed )
Supplement: 41467_2019_12746_MOESM1_ESM.pdf
Select a paper to view details